ANVISA registration

FASTLINE FIA CEA

Registration 80105220237. ANTÍGENO CARCINOEMBRIONÁRIO

Registration details

Registration number80105220237
Application number25351387816202463
Technical nameANTÍGENO CARCINOEMBRIONÁRIO
Risk classIII
Published on16/12/2024
ValidityValid until 16/12/2034

Registration holder

Legal nameKHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA
CNPJ04.299.232/0001-43

Manufacturer

  • KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA BRASIL

Other registrations held by KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDAview all

FR-IgG SORBENT SYM

80105220074

Tampão de Eluição para kits Q-PREVEN

80105220098

ZikV/DenV/ChikV Savyon

80105220105

LAMP COVID 19

80105220115

FASTLINE COVID-19 Ag

80105220116

DETECTA COVID

80105220117

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist